Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case

Central nervous system (CNS) involvement in multiple myeloma (MM) is a rare and challenging complication associated with poor prognosis and limited treatment options. Emerging T-cell directing therapies, such as bispecific antibodies (bsAbs) and chimeric antigen receptor T cells (CAR-T), have shown...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Yasa Gul Mutlu, Sureyya Yıgıt Kaya, Senem Maral, Elif Melek, Zafer Baslar, Leylagul Kaynar, Omur Gokmen Sevindik
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2023-10-01
Rangatū:	Frontiers in Immunology
Ngā marau:	Elranatamab multiple myeloma bispecific Ab BCMA CNS involvement
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1276295/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!